- In August 2026, Amdocs secured a multi-year agreement with Telefónica Chile to provide software and services, strengthening long-term operational collaboration in Latin America.
- This contract supports higher revenue visibility for Amdocs, reinforcing its role as a core technology partner to major telecom operators.
- We’ll now examine how this new Telefónica Chile agreement might influence Amdocs’ investment narrative built around recurring, high-visibility contracts.
Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
Amdocs Investment Narrative Recap
To own Amdocs, you need to believe its core billing, cloud and AI software will stay embedded in large telecom operators through recurring, high-visibility contracts. The new multi year Telefónica Chile deal slightly reinforces this story by adding another Latin American anchor customer, but it does not change the main near term catalyst, which is execution on cloud and AI projects, or the key risk around customer concentration and slower telco spending.
Among recent announcements, the Q3 FY2026 results stand out in this context: revenue grew modestly to US$1,174.9m, while net income fell sharply, partly due to a US$201.9m one off loss. That contrast between steady top line and pressured earnings underlines how sensitive Amdocs is to execution and large project cycles, even as new agreements like Telefónica Chile aim to support backlog and cash flow durability.
Yet behind that reassuring contract win, there is an underappreciated customer concentration risk that investors should be aware of...
Read the full narrative on Amdocs (it's free!)
Amdocs’ narrative projects $5.2 billion revenue and $930.4 million earnings by 2029.
Uncover how Amdocs' forecasts yield a $75.94 fair value, a 20% upside to its current price.
Exploring Other Perspectives
The lowest estimate analysts were already cautious, projecting revenue of about US$5.2 billion and earnings near US$845.9 million by 2029, and the Telefónica Chile deal could either ease their concerns about telco project pacing or leave their more pessimistic assumptions intact, which is why you should weigh how differently reasonable people can view the same stock.
Explore 7 other fair value estimates on Amdocs - why the stock might be worth over 2x more than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Amdocs research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Amdocs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amdocs' overall financial health at a glance.
Curious About Other Options?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
- Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com